Publications - Corcept Therapeutics

PUBLICATIONS

Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.

Reversal of Antipsychotic-Induced Weight Gain in Rats with Miricorilant, a Selective Glucocorticoid Receptor (GR) Modulator

Lee et al. • 2020 • 2020 Annual Meeting - American Psychiatric Association (APA)

Hypercortisolism (Cushing syndrome)

GRADIENT: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of a Selective Glucocorticoid Receptor Modulator, Relacorilant, in Patients With Autonomous Cortisol Secretion Due to Cortisol-Secreting Adrenal Adenoma(s)/Hyperplasia

Auchus et al. • 2020 • J Endocr Soc. Vol 4, Issue Suppl 1 April-May

Hypercortisolism (Cushing syndrome)

Hypercortisolism in Newly Diagnosed Type 2 Diabetes: A Prospective Study of 384 Newly Diagnosed Patients

Steffensen et al • 2019 • Horm Metab Res.

The Liver Meeting 2021 (American Association for the Study of Liver Diseases)

Kowdley et al • 2021 •

Hypercortisolism (Cushing syndrome)

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study

Pivonello et al • 2021 • Front. Endocrinol., 14 July 2021

Relacorilant With Nab-paclitaxel: Safety and Activity in Patients With Pancreatic Ductal Adenocarcinoma and Ovarian Cancer

Munster et al. • 2019 •

Hypercortisolism (Cushing syndrome)

Efficacy and Safety of the Selective Glucocorticoid Receptor Modulator, Relacorilant (up to 400 mg/day), in Patients With Endogenous Hypercortisolism

Pivonello et al. • 2019 • American Association of Clinical Endocrinologists (AACE) 28th Annual Scientific & Clinical Congress

Selective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male Mice

Koorneef et al. • 2018 • Endocrinology. 2018, 159(12):3925–3936

Selective glucocorticoid receptor (type II) antagonist prevents and reverses olanzapine-induced weight gain.

Belanoff et al. • 2010 • Diabetes Obes Metab. 2010;12(6):545-7.

Hypercortisolism (Cushing syndrome)

Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess: A Systematic Review and Meta-analysis

Elhassan et al • 2019 • Ann Intern Med.